ProPharma Group

ProPharma Group offers a comprehensive suite of bespoke solutions across the full product lifecycle. The company provides global solutions in regulatory sciences, clinical research, quality and compliance, pharmacovigilance, and medical information. Operating globally with a strategic presence in key international markets, ProPharma Group employs a Research Consulting Organization (RCO) model to deliver tailored solutions. The company supports a wide range of therapeutic areas including oncology, cardiovascular, CNS, and rare diseases. Utilizing enabling technologies like Prodigy, ProPharma Group enhances decision-making and value for its partners. The company also offers specialized services for MedTech, including product development, regulatory support, and digital health solutions. Additionally, ProPharma Group provides full-service CRO capabilities, functional service provision, and decentralized clinical trials. Engaging in strategic global partnerships, the company aims to enhance service delivery and client outcomes. ProPharma Group was recognized on the Inc. 5000 List of America’s Fastest-Growing Companies for 2023.